Pranlukast ≥98.0% (by HPLC)

Proveedor: TCI
Atención

Sinónimos: N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4(4-phenylbutoxy)benzamide, ONO 1078, N-(4-Oxo-2-(1H-tetrazol-5-yl)-4H-chromen-8-yl)-4-(4-phenylbutoxy)benzamide

P2115-25MG P2115-100MG
TCIAP2115-25MGEA 31 EUR
TCIAP2115-25MG TCIAP2115-100MG
Pranlukast ≥98.0% (by HPLC)
Pranlukast
Formula: C₂₇H₂₃N₅O₄
Pto. de fusión: 233°C
Temperatura de almacenaje: Nevera
Número MDL: MFCD00864631
Núm. CAS: 103177-37-3
Índice Merck: 14,07710
https://digitalassets.avantorsciences.com/adaptivemedia/rendition?id=0680804e9c13baac60b45478f2894f148c1a3608&vid=0680804e9c13baac60b45478f2894f148c1a3608&prid=web&clid=SAPDAM

Order Now

Resultados test especificaciones

Appearance White to Almost white powder to crystal
Purity (HPLC) min. 98.0 area%
Elemental analysis (Nitrogen) 14.00 to 15.00 %


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Más About VWR